Triamcinolone nasal spray is licensed for the treatment of seasonal and perennial nasal allergy symptoms. By reducing inflammation, the medicine can help relieve itching, sneezing, and stuffy or runny nose. This product is typically used once a day.
What Is Triamcinolone Nasal Spray?
Triamcinolone nasal spray (Nasacort® AQ, Nasacort® Allergy 24HR) is a drug licensed to treat sneezing, runny or stuffy nose, and nasal itching due to allergies (known medically as allergic rhinitis) in adults and children as young as two years old. Triamcinolone nasal spray can be used to treat both allergies that occur all year long (known as perennial allergies) and seasonal allergies.
It is available with a prescription as Nasacort AQ or without a prescription as Nasacort Allergy 24HR. These two products come in the same strength.
Nasacort AQ is made by sanofi-aventis. Nasacort Allergy 24HR is made by Chattem, Inc., a sanofi company.
How Does Triamcinolone Nasal Spray Work?
Allergies occur when a person's immune system reacts to normally harmless substances that do not bother most people. This immune system reaction is known as inflammation and involves several different types of cells and several different chemicals in the body.
Triamcinolone nasal spray is a corticosteroid, or simply "steroid" for short. Steroids can have many different effects in the body, including anti-inflammatory effects. Steroids decrease inflammation by limiting the body's ability to produce an immune system reaction. They can be effective for treating conditions such as allergies. However, long-term use can cause bothersome and sometimes serious side effects, and this limits the usefulness of many steroids. Because triamcinolone nasal spray is sprayed into the nose, its effects are generally limited to this area. This helps prevent many of the long-term side effects of steroids.
Nasacort AQ [package insert]. Bridgewater, NJ: sanofi-aventis U.S., LLC;September 2008.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed August 5, 2011.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2005.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed August 2, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click